Clinical trial Recruiting at 1 site Observational Ages 18 and up

Electronic archive for treating severe organ failure and liver transplantation

Official title: Electronic Archive of Internal Medicine for the Treatment of Severe Organ Failure and Liver Transplantation-MITIGO

Run by IRCCS Azienda Ospedaliero-Universitaria di Bologna · NCT06781502 · Data updated 2026-11-12

This study looks at medical records of patients with severe liver failure to see how well different treatments work and improve liver transplant care over the next 10 years.

More Liver Transplantation trials

Quick facts

Study typeObservational
Ages18 Years and up
SexAll
Enrollment10000 (estimated)
SponsorIRCCS Azienda Ospedaliero-Universitaria di Bologna
Academic / other
Locations1 site (Bologna, Bologna)
StatusRecruiting
StartedOctober 21, 2023
Main results expectedOctober 2033
Study endsOctober 2033
Registry record updatedJanuary 17, 2025
Trial IDNCT06781502 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are adults aged 18 and older diagnosed with acute or chronic liver disease or those who have undergone liver transplantation.

Probably not a fit

Patients without a diagnosis of liver disease or organ failure will not benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This observational study collects structured data from medical records of patients with acute or chronic liver failure. It includes both retrospective data from patients diagnosed since 2013 and prospective data from patients diagnosed after the study begins, continuing for a period of 10 years. The aim is to analyze treatment outcomes and improve understanding of liver transplantation and organ failure management.

Why it matters

Potential benefit: If successful, this study could enhance treatment strategies for patients with severe liver conditions and improve transplantation outcomes.

How similar studies have gone: Other observational studies have shown success in improving treatment outcomes for liver transplantation and organ failure, suggesting this approach is promising.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Diagnosis of acute or chronic liver disease or LT
* Age ≥ 18 years
* Obtaining informed consent

Exclusion Criteria:

* no one

Where it's running

  • IRCCS - Azienda Ospedaliero-Universitaria di Bologna
    Bologna, Bologna, Italy
    Recruiting

Study contacts

  • Principal investigator: Giovanni Vitale, MD — IRCCS Azienda Ospedaliero-Universitaria di Bologna
  • Study coordinator: Giovanni Vitale, MD
  • Email: giovanni.vitale@aosp.bo.it
  • Phone: 0512144187

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.